8-K//Current report
ENDRA Life Sciences Inc. 8-K
Accession 0001213900-25-103707
$NDRACIK 0001681682operating
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 29, 9:15 PM ET
Size
548.8 KB
Accession
0001213900-25-103707
Documents
- 8-Kea0263059-8k_endra.htmPrimary
CURRENT REPORT
- EX-1.1ea026305901ex1-1_endra.htm
AT-THE-MARKET ISSUANCE SALES AGREEMENT BY AND BETWEEN ENDRA LIFE SCIENCES INC. AND LUCID CAPITAL MARKETS, LLC, DATED OCTOBER 29, 2025
- EX-5.1ea026305901ex5-1_endra.htm
OPINION OF K&L GATES LLP
- GRAPHICex5-1_001.jpg
GRAPHIC
- EX-101.SCHndra-20251029.xsd
XBRL SCHEMA FILE
- EX-101.LABndra-20251029_lab.xml
XBRL LABEL FILE
- EX-101.PREndra-20251029_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-103707-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0263059-8k_endra_htm.xml
IDEA: XBRL DOCUMENT
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001681682
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 29, 8:00 PM ET
- Accepted
- Oct 29, 9:15 PM ET
- Size
- 548.8 KB